What is "Ozempic face"?
"Ozempic face" is the informal term — popularized by plastic surgeons and dermatologists — for the facial volume loss and gauntness that some patients experience during significant weight loss on GLP-1 medications like semaglutide and tirzepatide.
It's characterized by hollowing under the eyes, loss of fullness in the cheeks, more prominent facial bones, and overall aged appearance. The same phenomenon happens with any rapid significant weight loss — crash diets, bariatric surgery, illness. GLP-1 medications get their own term because they've made rapid, significant weight loss newly common among a large population.
Why it happens — the biology
Facial fat is distributed in discrete "fat compartments" that provide structural support and volume to the face. As we age, these compartments naturally lose volume — which is why faces develop hollows under the eyes and around the cheeks with age. Significant weight loss accelerates this process by physically reducing the size of these fat pads.
The skin overlying these fat compartments also loses support. In younger patients with good skin elasticity, it contracts back. In older patients — or with very rapid weight loss — the skin may not contract as well, leaving it somewhat lax or sagging.
Why does it look more pronounced than with exercise-based weight loss? Because GLP-1-driven weight loss tends to be faster. Slower weight loss gives skin more time to contract and adapt. The 15–22% body weight loss that GLP-1 medications produce over 12–18 months is faster than most people have ever lost weight before.
Who's most at risk
- Patients over 40: Skin elasticity decreases with age. Older patients have less ability to snap back after significant fat volume changes
- Patients losing very large amounts of weight: The more total fat lost, the more pronounced the facial volume loss
- Rapid losers: Faster weight loss = less time for skin adaptation
- Patients with lower starting body fat: Counterintuitively, leaner patients have less overall fat reserve, so facial fat loss represents a larger proportion of total available facial volume
- Patients with significant sun damage or smoking history: These factors impair skin elasticity and collagen production
How to minimize Ozempic face — what actually helps
Prioritize protein aggressively
Adequate protein preserves muscle and collagen during weight loss. Aim for 0.7–1g per pound of body weight daily. This is the single most impactful dietary intervention for preserving facial structure.
Slow your weight loss if possible
Slower titration = slower weight loss = more time for skin adaptation. Discuss with your provider whether a slower dose increase schedule makes sense for you.
Resistance training
Building and maintaining muscle mass helps overall body composition and facial fullness. Facial muscles are small but maintaining overall lean mass matters for appearance throughout the body.
Stay well hydrated
Dehydration significantly amplifies the gaunt appearance of volume loss. GLP-1 patients often under-hydrate due to reduced appetite. 8+ cups of water daily is minimum.
Collagen supplementation
Evidence for collagen peptide supplements is modest but growing. Some patients report improvement in skin quality with 10–15g daily. Low risk, reasonable upside.
Sun protection
UV damage degrades collagen and impairs skin elasticity. Daily SPF 30+ on the face slows ongoing damage that makes facial aging from weight loss more pronounced.
Medical and aesthetic interventions
For patients who experience significant Ozempic face, several aesthetic interventions have become increasingly common specifically because of the GLP-1 weight loss wave:
- Dermal fillers (hyaluronic acid): The most common treatment — restores volume to specific areas like under-eye hollows and cheeks. Results are immediate and last 9–18 months. Cost: $600–$1,500 per treatment session
- Biostimulators (Sculptra, Radiesse): Stimulate collagen production rather than adding immediate volume. Results develop over months and last longer. Better for overall skin quality improvement
- Skin tightening treatments (Ultherapy, Thermage): Use ultrasound or radiofrequency to stimulate collagen and tighten lax skin. Best for mild-moderate laxity
- Fat transfer: More invasive — takes fat from elsewhere in the body and injects it into the face. Longer-lasting than fillers but requires a procedure
These are cosmetic decisions and not medically necessary. Discuss any aesthetic interventions with a board-certified dermatologist or plastic surgeon — not your telehealth GLP-1 provider, who isn't qualified to advise on these.
The weight loss vs. appearance trade-off
This is worth naming honestly. The health benefits of losing 15–22% of body weight are substantial — reduced cardiovascular risk, lower blood pressure, improved blood sugar, better joint function, reduced cancer risk. The appearance change from Ozempic face is a cosmetic concern for many patients but a health improvement by most objective measures.
Many patients also find that the overall appearance improvements from weight loss — reduced face fullness from adiposity, improved complexion, better posture and energy — outweigh the facial volume concerns. But the concerns are real and worth taking seriously, particularly for older patients.
If Ozempic face is a significant concern for you, discuss it with your provider before starting. They can help you think through the trade-offs and whether a slower titration schedule or lower target weight makes sense for your situation.
Starting GLP-1 therapy with medical oversight
The best telehealth platforms include ongoing provider relationships — so questions like this can be addressed as they come up. DirectMeds offers real physician oversight from ~$99/month.
Check eligibility at DirectMeds →